With a rich background in venture capital, the fund manager has built a robust portfolio focusing on early-stage investments in technology and life sciences. Active primarily in the North American and European markets, they have successfully completed over 50 deals, leading to notable exits that highlight their strategic, operator-first approach. Their investment style emphasizes data-driven decision-making, allowing for the identification of high-potential startups poised for growth. The manager's expertise spans key sectors including software, healthcare, and advanced manufacturing, reflecting a thematic investment strategy geared towards innovation.